Crossmark

Glucagon-like peptide-1 receptor agonists (GLP1-RA) in the treatment of mitochondrial diabetes

Published Online: 2021-05-05

Published Print: 2021-09

Authors

Lebbar, Maha

Timsit, José

Luyton, Cédric

Marchand, Lucien https://orcid.org/0000-0001-9101-5002
License Information

Text and Data Mining valid from 2021-05-05

Version of Record valid from 2021-05-05
More Information

Article History

Received: 13 March 2021

Accepted: 22 April 2021

First Online: 5 May 2021

Declarations

:

: LM has received honoraria for speaking from Abbott, Lilly, Novo Nordisk and Sanofi. CL has received honoraria for speaking from Novo Nordisk and Lilly. ML and JT have no potential conflict of interest relevant to this article

: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

: Informed consent was obtained from all patients for being included in the study

Document is current